C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Top Cited Papers
- 1 November 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 1 (2) , 92-97
- https://doi.org/10.1161/circoutcomes.108.831198
Abstract
Background— The relationship of circulating levels of high-sensitivity C-reactive protein (CRP) with cardiovascular disease (CVD) risk, particularly with consideration of effects at intermediate levels of risk, has not been fully assessed. Methods and Results— Among 3006 offspring participants in the Framingham Heart Study free of CVD (mean age, 46 years at baseline), there were 129 hard coronary heart disease (CHD) events and 286 total CVD events during 12 years of follow-up. Cox regression, discrimination with area under the receiver operating characteristic curve, and net reclassification improvement were used to assess the role of CRP on vascular risk. In an age-adjusted model that included both sexes, the hazard ratios for new hard CHD and total CVD were significantly associated with higher CRP levels. Similar analyses according to increasing homocysteine level showed significant protective associations for hard CHD but not for total CVD. In multivariable analyses that included age, sex, systolic blo...Keywords
This publication has 33 references indexed in Scilit:
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimationStatistics in Medicine, 2004
- Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening MarkerAmerican Journal of Epidemiology, 2004
- Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk ScoreCirculation, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Probability of stroke: a risk profile from the Framingham Study.Stroke, 1991
- Prevalence of coronary heart disease in the framingham offspring study: Role of lipoprotein cholesterolsThe American Journal of Cardiology, 1980
- The framingham offspring study. Design and preliminary dataPreventive Medicine, 1975